Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells

Bei-Lei CAI; Xin-Xin WANG; Shu-Ying YU; Xue-Qin HUANG; Xia-Yan ZHANG; San-Hua FANG; Yun-Bi LU; Wei-Ping ZHANG; Er-Qing WEI.
Journal of Zhejiang University. Medical sciences ; (6): 139-144, 2011.
Artículo en Zh | WPRIM | ID: wpr-319819

Documentos relacionados

  1. Leukotriene D4 accelerates antigen-mediated mast cell responses via the cysteinyl leukotriene 1 receptor.
  2. Cysteinyl-maresin 3 inhibits IL-13 induced airway hyperresponsiveness through alternative activation of the CysLT<sub>1</sub> receptor.
  3. [Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells].
  4. Leukotriene D<sub>4</sub> paradoxically limits LTC<sub>4</sub>-driven platelet activation and lung immunopathology.
  5. Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.
  6. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
  7. Allergen challenge-induced changes in bone-marrow responses to leukotriene D<sub>4</sub>, nonsteroidal anti-inflammatory drugs and cytokines.
  8. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
  9. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
  10. Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation.